Metals, read this!
Looks like they borrowed some of my DD?! :-)
Uniprime Shares Soar On AIDS Treatment Claim
By Rick Jurgens, Staff Reporter
PHOENIX -(Dow Jones)- Uniprime Capital Acceptance Inc.'s stock price more than tripled Tuesday, turning the spotlight on a small Nevada company with a startling medical claim and a recent run-in with securities regulators.
Uniprime (UPCA) shares closed at $5, up $3.25, or 186%, on bulletin board volume of 5.2 million shares. Average daily volume is 84,000 shares. The stock traded as high as $7.938 on Tuesday.
Recent interest in the Las Vegas-based company, which runs car dealerships, apparently was sparked by a company release which said that it is the "majority stockholder" in New Technologies & Concepts Inc. New Technologies - which shares an office suite in Las Vegas with Uniprime, according to incorporation papers filed with Nevada's Secretary of State - claims to have successfully eradicated the HIV virus from some AIDS patients.
That claim comes eight months after Uniprime paid $15,000 as a penalty and cost reimbursement to settle charges that it violated securities rules by selling unregistered stock to the public, and by paying commissions to unlicensed sales representatives, according to a consent agreement signed by Uniprime Chief Executive Gary Tabb.
Uniprime paid more than $29,000 in commissions to unlicensed brokers who sold more than $290,000 in Uniprime stock to 60 Nevadans. Buyers included 19 who were ineligible to buy it under the private placement rules under which the stock was issued, according to the agreement.
Uniprime is traded through the bulletin board and said it is seeking a broker to make a market in its stock.
The company said it got its stake in New Technologies in exchange for stock in Uniprime, and a promise to help market the AIDS treatment developed by Alfred Flores, who is New Concepts' president. Flores "knows nothing about how to market anything," the company said, adding that Uniprime "knew nothing about HIV except that they didn't want to get it."
Flores has a laboratory in Portugal and successfully tested his treatment, which uses natural ingredients and no pharmaceuticals, on about a dozen Spanish AIDS patients, according to Uniprime. The formula is not patented but, Uniprime said it was talking to lawyers about seeking such protection.
Flores could not be reached for comment.
|
